{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:17:21Z","timestamp":1791217041482,"version":"4.1.0"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1097\/bor.0b013e3282fbd22a","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T22:25:13Z","timestamp":1236119113000},"page":"300-305","source":"Crossref","is-referenced-by-count":51,"title":["Antibodies to citrullinated proteins in arthritis: pathology and promise"],"prefix":"10.1097","volume":"20","author":[{"given":"Lars","family":"Klareskog","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Widhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Hermansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"R\u00f6nnelid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.gene.2003.12.038","article-title":"Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved noncoding segments and a new human gene, PADI6","volume":"330","author":"Chavanas","year":"2004","journal-title":"Gene"},{"key":"R2-13-20210128","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/bies.10357","article-title":"PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease","volume":"25","author":"Vossenaar","year":"2003","journal-title":"Bioessays"},{"key":"R3-13-20210128","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.biocel.2006.03.008","article-title":"Citrullination: a posttranslational modification in health and disease","volume":"38","author":"Gyorgy","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"R4-13-20210128","doi-asserted-by":"crossref","first-page":"30709","DOI":"10.1074\/jbc.271.48.30709","article-title":"Protein unfolding by peptidylarginine deiminase: substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin","volume":"271","author":"Tarcsa","year":"1996","journal-title":"J Biol Chem"},{"key":"R5-13-20210128","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1006\/bbrc.1998.8148","article-title":"Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages","volume":"243","author":"Asaga","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"R6-13-20210128","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1177\/002215549804601110","article-title":"Deimination of 70-kDa nuclear protein during epidermal apoptotic events in vitro","volume":"46","author":"Mizoguchi","year":"1998","journal-title":"J Histochem Cytochem"},{"key":"R7-13-20210128","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1006\/bbrc.1996.1240","article-title":"Preferential deimination of keratin K1 and filaggrin during the terminal differentiation of human epidermis","volume":"225","author":"Senshu","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"R8-13-20210128","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0003-4967(24)43389-X","article-title":"Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis","volume":"60","author":"Nogueira","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"R9-13-20210128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J Clin Invest"},{"key":"R10-13-20210128","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1021\/bi9925569","article-title":"Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D","volume":"39","author":"Pritzker","year":"2000","journal-title":"Biochemistry"},{"key":"R11-13-20210128","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/glia.10039","article-title":"Preparation of a monoclonal antibody to citrullinated epitopes: its characterization and some applications to immunohistochemistry in human brain","volume":"37","author":"Nicholas","year":"2002","journal-title":"Glia"},{"key":"R12-13-20210128","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/rheumatology\/kel202","article-title":"Citrullination in extra-articular manifestations of rheumatoid arthritis","volume":"46","author":"Bongartz","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"R13-13-20210128","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/ard.2005.049403","article-title":"Citrullination is an inflammation-dependent process","volume":"65","author":"Makrygiannakis","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R14-13-20210128","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/art.20584","article-title":"The presence of citrullinated proteins is not specific for rheumatoid synovial tissue","volume":"50","author":"Vossenaar","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R15-13-20210128","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R16-13-20210128","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.4049\/jimmunol.166.6.4177","article-title":"The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin","volume":"166","author":"Masson-Bessiere","year":"2001","journal-title":"J Immunol"},{"key":"R17-13-20210128","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar1149","article-title":"Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin","volume":"6","author":"Vossenaar","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"R18-13-20210128","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/art.22817","article-title":"Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis","volume":"56","author":"Bang","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R19-13-20210128","doi-asserted-by":"crossref","first-page":"R1421","DOI":"10.1186\/ar1845","article-title":"Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis","volume":"7","author":"Kinloch","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"R20-13-20210128","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/bmj.2.6182.97","article-title":"Antikeratin antibodies in rheumatoid arthritis","volume":"2","author":"Young","year":"1979","journal-title":"Br Med J"},{"key":"R21-13-20210128","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI117969","article-title":"The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies","volume":"95","author":"Sebbag","year":"1995","journal-title":"J Clin Invest"},{"key":"R22-13-20210128","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R23-13-20210128","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cair.2003.11.001","article-title":"Anti-CCP antibodies, a highly specific marker for (early) rheumatoid arthritis","volume":"4","author":"Vossenaar","year":"2004","journal-title":"Clin Appl Immunol Rev"},{"key":"R24-13-20210128","first-page":"511","article-title":"Antibodies to cyclic citrullinated peptides in psoriatic arthritis","volume":"32","author":"Bogliolo","year":"2005","journal-title":"J Rheumatol"},{"key":"R25-13-20210128","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/rheumatology\/keh686","article-title":"The clinical and genetic associations of anticyclic citrullinated peptide antibodies in psoriatic arthritis","volume":"44","author":"Korendowych","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"R26-13-20210128","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2004.032177","article-title":"Anticitrullinated peptide antibodies may occur in patients with psoriatic arthritis","volume":"64","author":"Vander Cruyssen","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R27-13-20210128","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/ard.2005.040998","article-title":"Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation","volume":"65","author":"Alenius","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R28-13-20210128","first-page":"1829","article-title":"Determination of anticyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis","volume":"31","author":"Low","year":"2004","journal-title":"J Rheumatol"},{"key":"R29-13-20210128","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1136\/ard.2003.019331","article-title":"Diagnostic accuracy of anticyclic citrullinated peptide antibodies in juvenile idiopathic arthritis","volume":"63","author":"Kasapcopur","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R30-13-20210128","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/art.20773","article-title":"Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis","volume":"52","author":"Ferucci","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R31-13-20210128","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/03009740510026634","article-title":"Anticyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population","volume":"34","author":"Kwok","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"R32-13-20210128","first-page":"47","article-title":"Erosive arthropathy: clinical variance in lupus erythematosus and association with anti-CCP case series and review of the literature","volume":"25","author":"Martinez","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"R33-13-20210128","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/s10165-004-0325-2","article-title":"Anticyclic citrullinated peptide antibodies in patients with mixed connective tissue disease","volume":"14","author":"Takasaki","year":"2004","journal-title":"Mod Rheumatol"},{"key":"R34-13-20210128","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","article-title":"Meta-analysis: diagnostic accuracy of anticyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis","volume":"146","author":"Nishimura","year":"2007","journal-title":"Ann Intern Med"},{"key":"R35-13-20210128","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/ard.2006.051391","article-title":"Diagnostic and predictive value of anticyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review","volume":"65","author":"Avouac","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R36-13-20210128","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.62.2.120","article-title":"Anticitrullinated protein\/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage","volume":"62","author":"Meyer","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R37-13-20210128","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/ard.62.5.427","article-title":"Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis","volume":"62","author":"Vencovsky","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R38-13-20210128","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.2003.014233","article-title":"Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP)","volume":"63","author":"Forslind","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R39-13-20210128","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6","article-title":"The prognostic value of anticyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis","volume":"43","author":"Kroot","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R40-13-20210128","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/ard.2004.033571","article-title":"Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression","volume":"64","author":"R\u00f6nnelid","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R41-13-20210128","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/ard.2003.016808","article-title":"Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project)","volume":"63","author":"Kastbom","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R42-13-20210128","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.1780350810","article-title":"Immunopathology of rheumatoid arthritis: antikeratin antibodies precede the clinical disease","volume":"35","author":"Kurki","year":"1992","journal-title":"Arthritis Rheum"},{"key":"R43-13-20210128","first-page":"2743","article-title":"Antifilaggrin antibodies within \u2018normal\u2019 range predict rheumatoid arthritis in a linear fashion","volume":"27","author":"Aho","year":"2000","journal-title":"J Rheumatol"},{"key":"R44-13-20210128","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantap\u00e4\u00e4-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R45-13-20210128","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R46-13-20210128","doi-asserted-by":"crossref","first-page":"R458","DOI":"10.1186\/ar1697","article-title":"Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity","volume":"7","author":"Lundberg","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"R47-13-20210128","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI25422","article-title":"Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis","volume":"116","author":"Kuhn","year":"2006","journal-title":"J Clin Invest"},{"key":"R48-13-20210128","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/art.21385","article-title":"Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins","volume":"52","author":"Huizinga","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R49-13-20210128","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/art.21739","article-title":"The HLA-DRB1 shared epitope alleles are primarily a risk factor for anticyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis","volume":"54","author":"van der Helm-van Mil","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R50-13-20210128","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1186\/ar1868","article-title":"PTPN22 polymorphism and anticyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease","volume":"8","author":"Johansson","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"R51-13-20210128","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1086\/516736","article-title":"Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis","volume":"80","author":"K\u00e4llberg","year":"2007","journal-title":"Am J Hum Genet"},{"key":"R52-13-20210128","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1186\/ar2214","article-title":"The PTPN22 1858C\/T polymorphism is associated with anticyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden","volume":"9","author":"Kokkonen","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"R53-13-20210128","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa073491","article-title":"TRAF1-C5 as a risk locus for rheumatoid arthritis: a genomewide study","volume":"357","author":"Plenge","year":"2007","journal-title":"N Engl J Med"},{"key":"R54-13-20210128","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/art.22704","article-title":"Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis","volume":"56","author":"Sigurdsson","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R55-13-20210128","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1002\/art.22813","article-title":"Association of arthritis with a gene complex encoding C-type lectin-like receptors","volume":"56","author":"Lorentzen","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R56-13-20210128","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/art.22597","article-title":"Strong combined gene-environment effects in anticyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case\u2013control study in Denmark","volume":"56","author":"Pedersen","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R57-13-20210128","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.171.2.538","article-title":"Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule","volume":"171","author":"Hill","year":"2003","journal-title":"J Immunol"},{"key":"R58-13-20210128","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1902\/jop.1987.58.9.607","article-title":"Human leukocyte antigen (HLA) DR4: positive association with rapidly progressing periodontitis","volume":"58","author":"Katz","year":"1987","journal-title":"J Periodontol"},{"key":"R59-13-20210128","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/ard.2005.036913","article-title":"The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction","volume":"65","author":"Marotte","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R60-13-20210128","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/art.21629","article-title":"Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anticitrullinated protein antibodies in rheumatoid arthritis","volume":"54","author":"Pratesi","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R61-13-20210128","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/498651","article-title":"Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4","volume":"77","author":"Plenge","year":"2005","journal-title":"Am J Hum Genet"},{"key":"R62-13-20210128","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1002\/art.21294","article-title":"Association of the PTPN22 C1858T single-nucleotide polymorphism with rheumatoid arthritis phenotypes in an inception cohort","volume":"52","author":"Wesoly","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R63-13-20210128","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa073003","article-title":"STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus","volume":"357","author":"Remmers","year":"2007","journal-title":"N Engl J Med"},{"key":"R64-13-20210128","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1073\/pnas.79.11.3632","article-title":"Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis","volume":"79","author":"Klareskog","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R65-13-20210128","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/art.22525","article-title":"Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial","volume":"56","author":"van Dongen","year":"2007","journal-title":"Arthritis Rheum"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0b013e3282fbd22a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T23:59:27Z","timestamp":1738972767000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-200805000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e3282fbd22a","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}